Health & Fitness

According to FutureWise analysis the market for biopreservation is expected to reach US$ 8.36 billion by 2031 at a CAGR of 9.30%. Biopreservation is an essential procedure in the fields of biotechnology and life sciences that focuses on preserving biological materials such as cells, tissues, organs, and genetically engineered products under controlled conditions. The primary goal is to maintain the viability, stability, and functionality of these materials over time. This technique is crucial not only for long-term storage and transportation of biological samples used in research and clinical settings but also for applications in regenerative medicine and biopharmaceutical production. At its core, biopreservation aims to slow down or halt biological degradation and metabolic activity by employing low-temperature storage methods, including refrigeration, freezing, or cryopreservation. Cryopreservation, which involves storing biological samples at ultra-low temperatures with the use of ... Continue reading →

According to FutureWise analysis the market for bioprocess containers and fluid transfer solutions in 2023 is US$ 4.81 billion, and is expected to register a CAGR of 12.7% in 2023-2031 Bioprocess containers and fluid transfer solutions are critical components in contemporary biomanufacturing and biopharmaceutical production. These systems provide secure, sterile, and flexible methods for the handling, storage, and transportation of essential materials such as liquids, buffers, and cell cultures. Their significance is evident throughout both upstream and downstream bioprocessing workflows, as they ensure product integrity, reduce contamination risks, and facilitate the production of high-quality biologics, vaccines, and cell and gene therapies. Typically constructed from multilayer polymer films, bioprocess containers come in various formats, including 2D bags, 3D bags, and tank liners. They are utilized in key processes such as media preparation, buffer storage, and final product ... Continue reading →

According to FutureWise analysis the market for cell disruption in 2023 is US$ 5.25 billion, and is expected to reach US$ 14.07 billion by 2031 at a CAGR of 13.10%. Cell disruption is a fundamental process in biotechnology and bioprocessing, involving the breakdown of cell walls or membranes to release intracellular components like proteins, nucleic acids, enzymes, and other biomolecules. This step is critical for the recovery and purification of valuable biological products derived from microbial, plant, or animal cells, facilitating their use in research, diagnostics, and industrial production. The effectiveness of cell disruption significantly influences product yield, purity, and overall process economics, underscoring its importance in biomanufacturing. Cell disruption methods can be categorized into two main types: mechanical and non-mechanical. Mechanical methods, which include high-pressure homogenization, bead milling, ultrasonication, and freeze-thaw cycles, physically break ... Continue reading →

According to FutureWise analysis the market for diet pills in 2025 is US$ 1.67 billion, and is expected to reach US$3.86 billion by 2033 at a CAGR of 11.04%. The weight management market is expanding due to rising obesity rates and a growing focus on fitness. Increased availability of prescription and over-the-counter diet pills, along with advancements in formulation safety, is driving this growth. Additionally, the integration of digital health platforms and personalized nutrition plans is enhancing the effectiveness and accessibility of weight-loss solutions. Diet pills, also referred to as weight-loss supplements or anti-obesity medications, are designed to assist individuals in managing their body weight. These products aim to achieve weight reduction through various mechanisms, such as appetite control, metabolism enhancement, or fat absorption inhibition. They come in multiple forms, including prescription medications, over-the-counter supplements, and herbal formulations. The ... Continue reading →

According to FutureWise analysis the Differentiated Thyroid Cancer Therapeutics Market in 2025 is US$ 0.58 billion, and is expected to reach US$ 2.12 billion by 2033 at a CAGR of 17.59%. Market growth is fueled by the increasing prevalence of thyroid disorders and the demand for advanced treatments, such as targeted therapies. The development of new tyrosine kinase inhibitors (TKIs) and precision medicine is enhancing treatment outcomes, while rising healthcare investments and clinical research are driving innovation in differentiated thyroid cancer therapies. Differentiated thyroid cancer (DTC) represents the most prevalent type of thyroid malignancy, constituting nearly 90% of all thyroid cancer cases. This category primarily includes papillary and follicular thyroid cancers, which arise from thyroid follicular epithelial cells. Although DTC typically has a favorable prognosis and a high survival rate, particularly when identified at an early stage, a subset of patients may ... Continue reading →

According to FutureWise analysis, the Diabetes Care Devices Market in 2025 is US$36.45 billion and is expected to reach US$90.38 billion by 2033 at a CAGR of 12.02%. The integration of artificial intelligence (AI) and the Internet of Things (IoT) into diabetes management devices is fundamentally transforming personalized healthcare solutions. These innovative technologies enable real-time monitoring and comprehensive data analysis, resulting in customized treatment plans tailored to each patient's unique needs. Consequently, users can achieve greater control over their diabetes, leading to better health outcomes. North America currently leads the market for these advanced diabetes management solutions, largely due to its established healthcare infrastructure, extensive access to cutting-edge medical technologies, and a high prevalence of diabetes within its population. These factors have created a favorable environment for the swift adoption of innovative management ... Continue reading →

According to FutureWise analysis the market for difficult-to-express proteins in 2025 is US$ 4.89 billion, and is expected to reach US$ 11.36 billion by 2033 at a CAGR of 11.11%. The growth of the market can be attributed to an increasing demand for complex therapeutic proteins, which play a crucial role in biopharmaceutical development and precision medicine. Furthermore, rising investments in research and development, along with collaborations between biotechnology companies and academic institutions, are fostering innovations in the efficient production of proteins that are typically difficult to express. Difficult-to-express (DTE) proteins are a category of complex or unstable proteins that present significant challenges in production using standard expression systems. The difficulties arise from factors such as poor solubility, improper folding, low yield, and host-cell toxicity. Many DTE proteins are critical components in biological processes and disease mechanisms, including ... Continue reading →

According to FutureWise analysis, the Diabetic Eye Disease Devices Market in 2025 is US$2.31 billion and is expected to reach US$4.75 billion by 2033, at a CAGR of 9.43%. The growth of the diabetic eye disease devices market is heavily influenced by the increasing prevalence of diabetic retinopathy, which affects nearly one-third of people living with diabetes globally. Digestive health products encompass a wide range of supplements, functional foods, beverages, and pharmaceuticals designed to support and maintain a healthy gastrointestinal (GI) system. These products aim to improve digestion, enhance nutrient absorption, and balance gut microbiota while preventing or alleviating digestive disorders such as bloating, constipation, acid reflux, and irritable bowel syndrome (IBS). As awareness grows about the crucial role gut health plays in overall well-being, digestive health products have become essential in modern wellness and preventive healthcare. The human digestive system houses ... Continue reading →

According to FutureWise analysis, the diabetic macular edema market in 2025 is US$3.82 billion, and is expected to reach US$4.59 billion by 2033 at a CAGR of 2.32%.  The market for diabetic macular edema (DME) is profoundly influenced by the widespread use of anti-VEGF (vascular endothelial growth factor) therapies, which have become the gold standard for treating this serious ocular condition that poses a significant risk to vision. These innovative therapies are specifically designed to target and inhibit the pathological processes that drive abnormal blood vessel growth and fluid leakage in the retina, thereby mitigating disease progression and improving visual acuity for patients. Among the primary treatment options, intravitreal injections of medications such as ranibizumab (marketed as Lucentis), aflibercept (known as Eylea), and bevacizumab (commonly referred to as Avastin) account for a major share of the DME market's revenue stream. Each of these anti-VEGF ... Continue reading →

According to FutureWise analysis the market for digestible sensors is expected to reach US$ 12.01 billion by 2033 at a CAGR of 17.50%. The increasing adoption of innovative healthcare technologies is driving growth in real-time monitoring for medication adherence and physiological parameters. Digestible sensors are enhancing patient care through non-invasive diagnostics and personalized treatment. Furthermore, improvements in biocompatible materials and wireless communication are boosting sensor performance and safety, promoting their integration into digital health ecosystems. Digestible sensors, also known as ingestible sensors or smart pills, represent a significant advancement at the intersection of biotechnology, electronics, and digital health. These miniaturized electronic devices are designed to be swallowed and operate within the gastrointestinal (GI) tract, monitoring physiological conditions, medication adherence, or disease states in real time. Once ingested, they ... Continue reading →